Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Many HIV-Infected Kids Could Use Cheaper Treatment Safely

    For HIV-infected children in the developing world, treatment choices have been limited by concerns over the possible development of resistance to drugs they received as infants during failed attempts to prevent their infection in the first place.

  • Cord-blood-derived stem cell treatments safe
    Cord-blood-derived stem cell treatments safe

     In an article published in the Journal of Translational Medicine, Chinese stem cell research company Beike Biotechnology, reported positive safety data in 114 patients who were treated by doctors at Nanshan Affiliated Hospital of Guangdong Medical College in Shenzhen, using Beike's proprietary cord blood stem cell transplantation protocol.

  • How Often Do Antidepressants Make People Suicidal?
    How Often Do Antidepressants Make People Suicidal?

    NEW YORK (Reuters Health) Sep 02 - Antidepressants rarely trigger suicidal thoughts or behaviors, suggests a large study of patients in European psychiatric hospitals.

    But some experts question the data in the study, saying suicidal thoughts or behaviors were probably written off as part of the patient's illness, or that some cases of patients feeling or acting suicidal might have been missed altogether.

  • Pharmacy Council of India has not approved of 2nd Shift courses in colleges
    Pharmacy Council of India has not approved of 2nd Shift courses in colleges

    The Pharmacy Council of India is a statutory body constituted under section 3 of the Pharmacy Act, 1948.  The Council is empowered to prescribe minimum standard of education and to approve courses of study and examinations for the purpose of qualifying for registration as a pharmacist under section 10 & 12 of said Act.

  • Inform All: FDA Warns Consumers to Avoid TimeOut Capsules
    Inform All: FDA Warns Consumers to Avoid TimeOut Capsules

    The U.S. Food and Drug Administration is warning consumers not to take TimeOut Capsules because it contains an active drug ingredient that can dangerously lower blood pressure. The product is marketed as a dietary supplement for sexual enhancement.

  • Study: Presence of murine leukemia virus related gene sequences found in CFS patients
    Study: Presence of murine leukemia virus related gene sequences found in CFS patients

    Researchers have found murine leukemia viruses (MLV) related gene sequences in blood samples collected from patients diagnosed with chronic fatigue syndrome (CFS) and some healthy blood donors, according to a study published online today by the scientific journal Proceedings of the National Academy of Sciences (PNAS).

  • Direct Relationship Seen Between Plasma Amyloid Levels and Cognitive Decline
    Direct Relationship Seen Between Plasma Amyloid Levels and Cognitive Decline

    There is a direct and linear association between plasma beta-amyloid (Aβ) levels and multiple aspects of cognitive decline over time, including cognitive changes that constitute conversion to Alzheimer's disease, according to new findings from a population-based, ethnically diverse longitudinal sample of older adults.

  • More cases of supplying substandard drugs to CGHS come out
    More cases of supplying substandard drugs to CGHS come out

    Despite denials by the Government and stern measures including the introduction of special barcode, the supply of sub-standard drugs for the Central Government Health Scheme (CGHS) and pilferage of drugs continue in many places, it is learnt.

  • Gentamicin Surgical Sponge Ineffective in Decreasing Infection Rate
    Gentamicin Surgical Sponge Ineffective in Decreasing Infection Rate

    Prophylactic gentamicin-collagen sponges do not appear to significantly decrease infection rate compared with no intervention in patients undergoing colorectal surgery, according to the findings of a large randomized phase 3 trial.

  • US FDA accepts NDA for Gadovist injection in magnetic resonance imaging
    US FDA accepts NDA for Gadovist injection in magnetic resonance imaging

    Bayer Schering Pharma AG, Berlin, Germany, announced that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the US for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance imaging (MRI).

    [adsense:336x280:8701650588]

Subscribe to Pharma News